Research programme: biologics - Navya Biologicals

Drug Profile

Research programme: biologics - Navya Biologicals

Alternative Names: NAV 002; NAV 003; NAV 004; NAV 005; NAV 007; NAV 008; NAV 009; NAV 010; NAV 012; NAV 013

Latest Information Update: 29 Nov 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Navya Biologicals
  • Class Biological peptides; Biological proteins
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Autoimmune disorders; Inflammatory bowel diseases; Renal failure; Unspecified
  • Research Age-related macular degeneration; Cancer; Infertility; Myocardial infarction

Most Recent Events

  • 25 Nov 2016 Early research in Age-related macular degeneration in India (unspecified route)
  • 25 Nov 2016 Early research in Cancer in India (unspecified route)
  • 25 Nov 2016 Early research in Infertility in India (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top